Astellas Pharma US, Inc. Is 2006 Recipient Of The American Urological Association Annual Health Science Award
ATLANTA, May 16 /PRNewswire/ -- The American Urological Association is pleased to announce that Astellas Pharma US, Inc. (formerly Yamanouchi Pharmaceutical Co., Ltd.) is the recipient of this year's AUA Health Science Award. The award will be given at the Annual Awards Banquet during the 101st Annual Scientific Meeting of the AUA in Atlanta later this month.
The AUA Health Science Award is given each year to recognize one company that has continually exemplified the AUA's mission -- to promote the highest standards of urological clinical care through education (including continuing medical education, or CME), research and in the formulation of health care policy. It is only with the patronage of companies such as Astellas that the AUA can succeed in attaining its goals and helping the urologic community. Astellas has also been instrumental in supporting the "Rising Star in Urology Research Awards" program. The recipient of the award is selected by the AUA Awards Committee.
"Astellas has shown continued interest in AUA education and research initiatives," said AUA Associate Executive Director of Development and Publications Kevin Wohlfort. "With the support of such a committed organization, the AUA has been able to fulfill its mission, and take urologic care to the next level."
"We at Astellas are committed to making a difference in urology and appreciate the opportunity to partner with the American Urology Association to achieve this goal," said Yoshihiko Hatanaka, President and CEO of Astellas Pharma US, Inc. "Astellas is honored to receive AUA's recognition of our efforts and look forward to continuing our partnership to further the study and practice of urology."
Astellas Pharma US, Inc. is a subsidiary of Astellas Pharma, Inc., located in Tokyo. The company is dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is the pre-eminent professional organization for urologists, with more than 13,000 members throughout the world. An educational nonprofit organization, the AUA pursues its mission of fostering the highest standards of urologic care by carrying out a wide variety of programs for members and their patients, including UrologyHealth.org, an award-winning on-line patient education resource, and the American Urological Association Foundation, Inc., formerly AFUD.
About Astellas Pharma US, Inc.: Astellas Pharma US, Inc. is a subsidiary of Astellas Pharma, Inc., located in Tokyo, a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. In April 2005, the company was formed through the merger of Fujisawa Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. The organization is committed to becoming a global mega pharmaceutical company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. For more information about Astellas, please visit http://www.astellas.com/us .
Contact: AUA Press Suite (May 19 - May 24) 404-222-5932 AUA Communications Office (prior to and after meeting) 410-689-3932Astellas Pharma US, Inc.
CONTACT: AUA Press Suite (May 19 - May 24), +1-404-222-5932, or AUACommunications Office (prior to and after meeting), +1-410-689-3932
Web site: http://www.astellas.com/us/